Please login to the form below

Not currently logged in
Email:
Password:

Redx poaches AstraZeneca senior executive

Lisa Anson joins the UK biotech as its CEO

Lisa AnsonDrug discovery and development group Redx Pharma has appointed its new chief executive officer in the form of Lisa Anson.

Anson, who was previously AstraZeneca’s UK president since 2012, also joins Redx’s board of directors, taking up both roles on 1 June.

With a 20-year career with AstraZeneca, Anson has held a variety of senior management roles at the pharmaceutical company, situated in both the US and UK, including global vice president oncology, and vice president of emerging brands, working closely with the research and development teams.

Ian Ross, executive chairman of Redx, said: “Lisa has been tasked by the board to lead the re-launch of the company and to take the steps necessary to build a substantial biotech company built upon an innovative science base, selectively acquiring additional assets.

“Lisa is a consummate business professional, who brings a wealth of relevant experience from the international pharmaceutical and biotech sector and I am confident that she is the right person to grow this company into a very excising and meaningful entity that has the potential to create both important new medicines for patients and generate significant value for shareholders."

27th April 2018

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....